tiletamine hydrochloride has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Fang, Q; Huang, Y; Liang, G; Miao, L; Pan, Y; Peng, K; Sun, Y; Tong, C; Wang, Y; Wang, Z; Zhao, Y | 1 |
| Cai, L; Cai, Y; Feng, Z; Hu, J; Li, J; Li, X; Liang, G; Pan, Y; Wang, Y; Yang, S; Yu, C | 1 |
2 other study(ies) available for tiletamine hydrochloride and Diabetic Nephropathies
| Article | Year |
|---|---|
Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
Topics: Angiotensin II; Animals; Benzylidene Compounds; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Renin-Angiotensin System; Signal Transduction; Streptozocin | 2014 |
Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylidene Compounds; Blood Glucose; Blotting, Western; Body Weight; Cell Culture Techniques; Cell Movement; Curcumin; Cyclohexanones; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Fibrosis; Glucose; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Organ Size; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction | 2012 |